Across TCGA pan-cancer cohorts, RING1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RING1 data layer compared with 23 for mass-spec protein and 8 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RING1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated RING1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC are the cancer types where RING1 Mutation most reproducibly stratifies survival.